Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label Study of Isotretinoin in Mild to Moderate Alzheimer's Disease

NCT01560585 is registered in ClinicalTrials.gov with University Hospitals Cleveland Medical Center as lead sponsor.

NCT NCT01560585
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01560585 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label Study of Isotretinoin in Mild to Moderate Alzheimer's Disease
Lead sponsor
University Hospitals Cleveland Medical Center
Phase
Phase 1/2
Overall status
Terminated
Start date
April 30, 2012
Completion date
August 31, 2014
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease